Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Leipzig |
---|---|
Information provided by: | University of Leipzig |
ClinicalTrials.gov Identifier: | NCT00491036 |
Patients in cardiogenic shock complicating acute myocardial infarction (AMI) are referred to a tertiary care center for percutaneous coronary intervention (PCI) of the infarct related artery in this multicenter, ran-domized clinical trial. After checking in- and exclusion criteria computerized randomization is performed to either PCI plus intraaortic balloon pump (IABP) insertion and medical treatment or PCI plus medical treatment only.
Intensive care treatment is performed according to standard care including hemodynamic monitoring using a pulmonary artery catheter for optimal volume status adaptation and inotropic drug administration. The IABP will be weaned after hemodynamic stabilization. Primary outcome measure will be 30-day mortality. The secondary outcome measures such as hemody-namic, laboratory and clinical parameters will serve as surrogate for prognosis of the patients.
Condition | Intervention |
---|---|
Myocardial Infarction Shock, Cardiogenic |
Device: Intraaortic balloon pump |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Randomized Clinical Study of Intraaortic Balloon Pump Use in Cardiogenic Shock Complicating Acute Myocardial Infarction |
Study Start Date: | January 2008 |
Estimated Study Completion Date: | August 2010 |
Ages Eligible for Study: | 18 Years to 90 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Cardiogenic shock complicating acute myocardial (STEMI or NSTEMI) with:
Signs of impaired organ perfusion:
Hemodynamic parameters:
Exclusion Criteria:
Contact: Holger Thiele, MD | +49 341 8651426 | thielh@medizin.uni-leipzig.de |
Study Chair: | Holger Thiele, MD | University of Leipzig |
Study ID Numbers: | 342 |
Study First Received: | June 22, 2007 |
Last Updated: | June 22, 2007 |
ClinicalTrials.gov Identifier: | NCT00491036 History of Changes |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Acute myocardial infarction cardiogenic shock percutaneous coronary intervention intraaortic balloon counterpulsation Acute myocardial infarction – cardiogenic shock |
Necrosis Heart Diseases Shock Shock, Cardiogenic Myocardial Ischemia |
Vascular Diseases Ischemia Infarction Myocardial Infarction |
Necrosis Heart Diseases Pathologic Processes Shock, Cardiogenic Shock Myocardial Ischemia |
Vascular Diseases Cardiovascular Diseases Ischemia Infarction Myocardial Infarction |